HF

Health for Life Capital fund

Europe, Ile-de-France, France, Paris

Description

Health for Life Capital Fund is managed by Seventure Partners, which invests in the biotechnology and life science areas.

Investor Profile

Health for Life Capital fund has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (25%)
  • Series D (25%)
  • Debt Financing (13%)
  • Series C (13%)
  • Series E (13%)
  • Series Unknown (13%)

Country Focus

  • France (50%)
  • United States (38%)
  • Japan (13%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Care
  • Life Science
  • Medical
  • Pharmaceutical
  • Advanced Materials
  • Agriculture
  • Food And Beverage
  • Nutrition
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Health for Life Capital fund frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Closed Loop Capital
North America, Pennsylvania, United States, Radnor
Co-Investments: 1
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7
Principia SGR
Europe, Lombardia, Italy, Milan
Co-Investments: 3
European Investment Bank
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Bunge
North America, New York, United States, White Plains
Co-Investments: 1
Ajinomoto
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Nestlé Health Science
Europe, Vaud, Switzerland, Vevey
Co-Investments: 4

What are some of recent deals done by Health for Life Capital fund?

Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series DJul 21, 2021
Amount Raised: $68,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
Axial Biotherapeutics

Woburn, Massachusetts, United States

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BFeb 27, 2019
Amount Raised: $25,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625
MycoTechnology

Aurora, Colorado, United States

MycoTechnology utilizes fungi-based food-processing platforms to transform the flavor and value of agricultural products.

Advanced MaterialsAgricultureBiotechnologyFood and BeverageNutritionOrganic FoodProfessional Services
Series BAug 29, 2017
Amount Raised: $42,000,000
Anaeropharma Science

Tokyo, Tokyo, Japan

Anaeropharma is a biopharmaceutical company engaged in research and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series UnknownJul 5, 2017
Amount Raised: $13,200,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series CApr 20, 2016
Amount Raised: $16,385,662